Page 17 - Vaccine

With mRNA vaccine, India will have flexibility against Covid-19: Scientist

The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) recently announced the development of the country's first potential mRNA vaccine candidate to fight against SARS-CoV-2

SII, Symbiosis to set up research centre for vaccine development

Serum Institute of India on Friday said it has signed an agreement with the Symbiosis International University earlier this month to set up a research centre for vaccines and biologicals. The R&D (Research & Development) centre will lead the development of new vaccines, technologies, products and innovations in immunisation practices that provide equitable access to life-saving interventions, especially across Low- and Middle-Income Countries (LMICs). The entity will work towards improving health equity against future pandemics and infectious diseases. It will also ensure cross-programme coordination and collaboration, as the facility will be an ecosystem that would also have R&D centres for stem cells, nanotechnology, medical image analysis, applied artificial intelligence and waste resource management, among others. "The research centre will be instrumental in advancing indigenous capabilities for end-to-end development of any futuristic technology and projects in the ...

Govt may not allow mixing of Covid-19 vaccines for booster shots

On May 4, Biological E submitted an application seeking emergency use authorisation for its Covid vaccine Corbevax as a booster dose in adults fully vaccinated with Covishield or Covaxin

What is Corbevax, the Covid-vaccine for your 5-year-old?

The DCGI has recently approved the emergency use of Covid-19 vaccine Corbevax for children aged five to 12. Find out more about the new vaccine and how it can boost the immune response

NTAGI meet this week to review vaccine data for 5-12 age group

A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children

SII's Covovax vaccine now available for 12-17 age group at private centres

A dose of Covovax will cost Rs 900 plus GST, in addition to hospital service charge of Rs 150, official sources told PTI

Covid booster shots won't be mandatory for all, says K Srinath Reddy

As cases of Covid-19 are rising in India, Business Standard's Bhaswar Kumar spoke to K Srinath Reddy, president of Public Health Foundation of India, about how the fourth wave is likely to play out

India faces global challenges from position of strength, says RBI article

The article on 'State of the Economy', published in the April 2022 RBI Bulletin, said India enters Samvat 2079 having crested the third wave of the pandemic

Kejriwal govt should provide free booster dose: Delhi Congress president

He said that the lockdown and closure of schools will not be the solution to deal with the pandemic

Covid-19: Delhi govt says free precaution doses at its hospitals soon

The move comes as the national capital witnesses an uptick in coronavirus cases and a rise in positivity rate

SII, Bharat Biotech cut Covid vaccine prices for pvt hospitals to Rs 225

SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far

Cadila Pharma launches world's first novel 3-dose vaccine against rabies

The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology

Govt okays booster Covid shot for all adults at private centres from Apr 10

Around 22.8 mn precaution or booster dose have been administered to healthcare and frontline workers along with senior citizens after the population segments opened up in the first week of January.

CoWIN now allows submitting request to rectify Covid vaccination date

The portal already has a feature that allows one to rectify inadvertent errors in name, year of birth and gender on vaccination certificates

Don't slack off

Vaccination programme cannot lose govt attention

SII, Bharat Biotech halt production of Covid vaccines as demand slips

High inventory, lack of fresh orders behind the decision; focus on non-Covid vax

US lawsuit may not impact India launch of Gennova's mRNA vaccine

The vaccine is now under review by the regulator, and if approved, it may be ready for launch in the Indian market and will be the first mRNA Covid vaccine to be available here.

Bharat Biotech slows down Covaxin production as it sees decrease in demand

'For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities,' the Hyderabad-based company said

'India may come up with vaccine against tuberculosis by 2024'

Currently, the BCG vaccine is used among children at the time of birth

Finland recommends fourth Covid-19 vaccine dose to people above 80 years

Finland has recommended a fourth Covid-19 vaccine dose for people above 80 years and those living in care homes